Articles tagged with 'Women Health' & 'Cancer' | Cedars-Sinai Medical Center

Some soft tissue sarcomas, a rare type of cancerous tumor, are resistant to immunotherapy and chemotherapy treatment. But Cedars-Sinai Cancer investigators, in a study published in the peer-reviewed journal Nature Communications, have identified a …

Using spatial analysis of tissue samples, Cedars-Sinai investigators have identified patterns that could predict whether patients with the most common type of ovarian cancer will experience early relapse after treatment. These patterns, detailed in …

Bin Zheng, PhD, a specialist in targeted therapies and immunotherapy, has joined Cedars-Sinai Cancer as director of Melanoma Research in the Department of Biomedical Sciences. Zheng will work with Cedars-Sinai surgical and medical oncology …

Black women in the U.S. are three times more likely than white women to die, or become seriously ill, from pregnancy-related complications, according to the Centers for Disease Control and Prevention. Those disparities remain regardless of income or …

When Elisa Schoenfeld, a child development specialist, learned she had tested positive for a BRCA gene mutation, she knew it raised her risk for breast and ovarian cancer. She and her daughter, Amira, who received similar genetic test results, …

FINDINGSActive surveillance is an established practice for managing certain low-risk cancers that are unlikely to cause harm. It is an increasingly common and effective way to manage certain early-stage cancers, including those in the prostate, …

It is one of the most common and painful disorders, affecting more than 6 million women in the United States. Endometriosis is often difficult to diagnose and effectively treat. But Cedars-Sinai experts find patients can now benefit from minimally …

Berni Coleman, NP, PhD, director of Nursing Research and Quality Improvement and assistant professor of Biomedical Sciences at Cedars-Sinai, joined the International Transplant Nurses Society (ITNS) as a speaker at the group’s inaugural presentation …

For the fourth consecutive year, the Blood and Marrow Transplant Program in the Division of Hematology and Cellular Therapy at Cedars-Sinai has achieved higher than expected survival rates in patients receiving allogeneic stem cell …

Leo Mascarenhas, MD, MS, has an important message for parents whose children have been diagnosed with sarcoma, a type of cancer that develops in the bones or soft tissues.“For many children, there are treatment options and even a cure,” said …

Rebecca O’Brien turned scribbles on a notepad into an award-winning, one-woman show—and she never saw it coming. The unanticipated work of art helped her uncover the seed of humor after a stage 2 breast cancer diagnosis. Now, six years later, …

Cedars-Sinai investigators have used artificial intelligence (AI) to help computers access some of the most important and difficult-to-mine information in cancer patients’ medical records: pathology reports. Their method, described in the …

Gastrointestinal cancers were once diagnosed primarily by location. A tumor in the liver was liver cancer, while one in the pancreas was pancreatic. The few chemotherapy treatments available affected the entire patient—sometimes causing difficult …

The Department of Radiation Oncology at Cedars-Sinai Cancer has earned accreditation from the American Society for Radiation Oncology (ASTRO) Accreditation Program for Excellence. The certification marks the commitment to patient safety and quality …

FINDINGSCedars-Sinai Cancer investigators have discovered a protein expressed on multiple myeloma cancer cells that drives disease growth and development. The new study found that blocking part of the protein’s unique signaling pathway stops myeloma …

Chemotherapy can be toxic to heart cells. To help protect the hearts of cancer patients, Cedars-Sinai investigators have created a three-dimensional “heart-on-a-chip” to evaluate drug safety. In a study published in the peer-reviewed journal Lab on …

Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test for predicting pancreatic …

JanuaryCedars-Sinai Streamlines Lung Cancer ScreeningCedars-Sinai Cancer is taking on the country’s leading cause of cancer-related death with a new Lung Cancer Screening Program. Led by Sara Ghandehari, MD, the program is …

Women who received standard recommended immunizations during their pregnancy were more likely to accept the COVID-19 vaccine, according to new research from Cedars-Sinai. Investigators also identified disparities in vaccination linked to race and …

Cedars-Sinai Cancer investigators have analyzed the cells within triple-negative breast cancer tumors before and after radiation therapy with immunotherapy, identifying three patient groups with different responses to the treatment. Their study, …

New research from the Smidt Heart Institute at Cedars-Sinai found that women who developed signs of elevated blood pressure during pregnancy were more likely to have residual evidence of abnormal heart structure and function up to a decade after the …

Cedars-Sinai Cancer investigators have discovered a new way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant. Their study, published in the peer-reviewed Journal of Clinical Oncology, is …

Cedars-Sinai Cancer is part of an unconventional consortium dedicated to fighting cancer through the integration of diverse scientific disciplines. The effort, known as the Convergent Science Cancer Consortium, is funded through a $3.2 million grant …

Cedars-Sinai investigators have discovered how the liver defends itself against cancer. Their study, published in the peer-reviewed Journal of Hepatology, suggests targets for therapies to protect the liver both from cancers that originate there and …

Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality healthcare is equal, regardless of socioeconomic status. Their study, published today …

Huntington Health recently marked the two-year anniversary of its affiliation with Cedars-Sinai Health System. In this brief time, the relationship has brought important benefits to both organizations, their staffs and the patients they …

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer—both of which helped patients live longer without their disease progressing than the current standard treatment. The results …

Amanda Butler and Isabella Bugatti, both just entering their 30s, were blindsided by a diagnosis that is on the rise among women their age: breast cancer.They are not the only ones. A recent study in the peer-reviewed journal JAMA Network Open found …

Cedars-Sinai maternal-fetal medicine leader Kimberly Gregory, MD, MPH, is the new chair of the California Pregnancy-Associated Review Committee (CA-PARC).Formerly known as the California Pregnancy-Associated Mortality Review (CA-PARM), the committee …

Hematologist-oncologist Navid Hafez, MD, MPH, has joined The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, as director of Precision Medicine and Thoracic Oncology. Hafez will focus on clinical research programs to …